Eversept Partners, LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.29 Billion distributed in 86 stocks.

Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $106M, Natera, Inc. with a value of $83.6M, Vera Therapeutics, Inc. with a value of $81.3M, Syndax Pharmaceuticals Inc with a value of $53.4M, and Vaxcyte, Inc. with a value of $51.2M.

Examining the 13F form we can see an increase of $298M in the current position value, from $993M to 1.29B.

Eversept Partners, LP is based out at New York, NY

Below you can find more details about Eversept Partners, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.29 Billion
Healthcare: $1.14 Billion
ETFs: $138 Million
Basic Materials: $11.5 Million
Financial Services: $535,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 86
  • Current Value $1.29 Billion
  • Prior Value $993 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 29 stocks
  • Additional Purchases 25 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 24 stocks
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.